MX2012014783A - Composiciones de polietilenglicol para controlar recaida de herpes labialis, herpes genitalis, y herpes zoster. - Google Patents

Composiciones de polietilenglicol para controlar recaida de herpes labialis, herpes genitalis, y herpes zoster.

Info

Publication number
MX2012014783A
MX2012014783A MX2012014783A MX2012014783A MX2012014783A MX 2012014783 A MX2012014783 A MX 2012014783A MX 2012014783 A MX2012014783 A MX 2012014783A MX 2012014783 A MX2012014783 A MX 2012014783A MX 2012014783 A MX2012014783 A MX 2012014783A
Authority
MX
Mexico
Prior art keywords
herpes
relapse
polyethylene glycol
genitalis
zoster
Prior art date
Application number
MX2012014783A
Other languages
English (en)
Spanish (es)
Inventor
Peter Vitins
Marcel Langenauer
Paul Martin Scherer
Original Assignee
Devirex Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Devirex Ag filed Critical Devirex Ag
Publication of MX2012014783A publication Critical patent/MX2012014783A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/765Polymers containing oxygen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/765Polymers containing oxygen
    • A61K31/77Polymers containing oxygen of oxiranes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MX2012014783A 2010-07-08 2011-07-08 Composiciones de polietilenglicol para controlar recaida de herpes labialis, herpes genitalis, y herpes zoster. MX2012014783A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36232910P 2010-07-08 2010-07-08
PCT/IB2011/001919 WO2012004669A1 (en) 2010-07-08 2011-07-08 Polyethylene glycol compositions for controlling relapse of herpes labialis, herpes genitalis, and herpes zoster

Publications (1)

Publication Number Publication Date
MX2012014783A true MX2012014783A (es) 2013-04-03

Family

ID=44588123

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012014783A MX2012014783A (es) 2010-07-08 2011-07-08 Composiciones de polietilenglicol para controlar recaida de herpes labialis, herpes genitalis, y herpes zoster.

Country Status (20)

Country Link
US (2) US9814743B2 (enExample)
EP (1) EP2563374B1 (enExample)
JP (1) JP5858994B2 (enExample)
KR (1) KR101881175B1 (enExample)
CN (1) CN103079574B (enExample)
AU (1) AU2011275458B2 (enExample)
CA (1) CA2803228C (enExample)
DK (1) DK2563374T3 (enExample)
ES (1) ES2442928T3 (enExample)
HR (1) HRP20140135T1 (enExample)
IL (1) IL223582A (enExample)
MX (1) MX2012014783A (enExample)
PL (1) PL2563374T3 (enExample)
PT (1) PT2563374E (enExample)
RS (1) RS53162B (enExample)
RU (1) RU2643763C2 (enExample)
SG (1) SG186937A1 (enExample)
SI (1) SI2563374T1 (enExample)
WO (1) WO2012004669A1 (enExample)
ZA (1) ZA201300177B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2563374T3 (da) 2010-07-08 2014-01-20 Devirex Ag Polyethylenglycolsammensætninger til kontrol af tilbagefald af herpes labialis, herpes genitalis og herpes zoster
WO2013102885A1 (en) 2012-01-06 2013-07-11 Devirex Ag Hygroscopic compositions for controlling relapse of herpes labialis, herpes genitalis, and herpes zoster
WO2014130432A1 (en) 2013-02-19 2014-08-28 Johnson & Johnson Consumer Companies, Inc. Methods and compositions for improving appearance and formation of scar tissue
EP2803354B1 (de) * 2013-05-14 2015-03-04 NajöPharm GmbH i.G. Kombination aus Polyacrylsäure und 2-Amino-2-methylpropanol zur Verwendung in der Behandlung von Herpesinfektionen
AR110250A1 (es) * 2016-11-28 2019-03-13 Aicuris Anti Infective Cures Gmbh Formulación tópica que comprende n-[5-(aminosulfonil)-4-metil-1,3-tiazol-2-il]-n-metil-2-[4-(2-piridinil)-fenil]-acetamida
BR112021021972A2 (pt) 2019-05-03 2021-12-21 Hoffmann La Roche Métodos de redução de uma taxa de atividade de hidrólise enzimática, de redução do nível de uma ou mais enzimas hidrolíticas e de redução da degradação de um polissorbato, composições farmacêuticas e composições de porção de anticorpo formulada
US20210330700A1 (en) * 2020-04-23 2021-10-28 Johnson & Johnson Consumer Inc. Methods and compositions for inhibiting influenza viruses using low molecular weight hydrophobically modified polymers and polyalkylene glycols
EP4355297A1 (de) * 2020-04-30 2024-04-24 Ninoderm UG (Haftungsbeschränkt) Behandlungsmittel zur antiviralen therapie, applikator und verfahren zur herstellung eines behandlungsmittels

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4603122A (en) 1979-08-17 1986-07-29 Blough Herbert A Antiviral agent against herpes virus infections
GB2080682B (en) * 1980-07-30 1984-03-28 Ciba Geigy Ag Antiherpetically active lipstick
EP0087161A3 (en) 1982-02-24 1984-04-04 Key Pharmaceuticals, Inc. Isopropylmyristate 4-alkyl-2,6-(bis-tert-butyl)-phenol medicament
US5232700A (en) 1990-11-14 1993-08-03 The Administrators Of The Tulane Educational Fund Methods of prophylaxis and treatment of herpes simplex lesions utilizing piracetam as the active ingredient
NL9500216A (nl) * 1995-02-06 1996-09-02 Bio Pharma Sciences Bv Farmaceutische samenstelling voor de behandeling van herpes.
US6045823A (en) * 1996-09-19 2000-04-04 Dragoco Gerberding & Co. Ag Process for producing solid anhydrous composition, and pharmaceutical and cosmetic products comprising same
GB9902227D0 (en) * 1999-02-01 1999-03-24 Cipla Limited Pharmaceutical composition for topical administration
US8030260B2 (en) * 2005-03-25 2011-10-04 Chemsil Silicones, Inc Pre-shave compositions and methods of using same
DE202005007363U1 (de) 2005-05-04 2005-07-14 Anton Hübner GmbH & Co. KG Gegen Herpesbläschen verwendbare Kieselsäurezusammensetzungen
WO2008087034A2 (en) 2007-01-17 2008-07-24 Devirex Ag Cyclodextrin formulations
DK2563374T3 (da) 2010-07-08 2014-01-20 Devirex Ag Polyethylenglycolsammensætninger til kontrol af tilbagefald af herpes labialis, herpes genitalis og herpes zoster
WO2013102885A1 (en) 2012-01-06 2013-07-11 Devirex Ag Hygroscopic compositions for controlling relapse of herpes labialis, herpes genitalis, and herpes zoster

Also Published As

Publication number Publication date
KR20130142992A (ko) 2013-12-30
AU2011275458A1 (en) 2013-02-28
CA2803228A1 (en) 2012-01-12
ZA201300177B (en) 2014-03-26
JP2013530208A (ja) 2013-07-25
SI2563374T1 (sl) 2014-01-31
SG186937A1 (en) 2013-02-28
RS53162B (sr) 2014-06-30
KR101881175B1 (ko) 2018-07-23
US9814743B2 (en) 2017-11-14
AU2011275458B2 (en) 2014-11-27
HRP20140135T1 (hr) 2014-03-28
RU2013100383A (ru) 2014-08-20
WO2012004669A1 (en) 2012-01-12
US20180055875A1 (en) 2018-03-01
CN103079574A (zh) 2013-05-01
CN103079574B (zh) 2017-04-12
CA2803228C (en) 2019-03-12
PL2563374T3 (pl) 2014-04-30
IL223582A (en) 2017-12-31
PT2563374E (pt) 2014-01-23
EP2563374B1 (en) 2013-11-13
JP5858994B2 (ja) 2016-02-10
ES2442928T3 (es) 2014-02-14
DK2563374T3 (da) 2014-01-20
HK1180969A1 (en) 2013-11-01
RU2643763C2 (ru) 2018-02-05
US20130090389A1 (en) 2013-04-11
EP2563374A1 (en) 2013-03-06

Similar Documents

Publication Publication Date Title
MX2012014783A (es) Composiciones de polietilenglicol para controlar recaida de herpes labialis, herpes genitalis, y herpes zoster.
CR20130247A (es) Compuestos tricíclicos de la pi3k y métodos de uso
EP3483163A3 (en) Triazolo[4,5-d]pyrimidine derivatives as cb2 receptor antagonists
TR201907783T4 (tr) Benzosulfonamit türevleri, bileşimleri ve kanser hücrelerinin metastazının önlenmesinde kullanımları.
GEP201606555B (en) Compounds and compositions for modulating egfr activity
MY170878A (en) [1,2,3] triazolo [4,5-d] pyrimidine derivatives as agonists of the cannabinoid receptor 2
MX2016002185A (es) Formulacion combinada de dos compuestos antivirales.
MX346602B (es) Compuestos beta-lactamicos sustituidos con amidina, su preparacion y uso como agentes antibacterianos.
MX2014012477A (es) Inhibidores pirrolopirazona de tanquirasa.
WO2011113060A3 (en) Antiviral compounds and methods of use thereof
PH12014501026A1 (en) [1, 2, 3]triazolo[4,5-d] pyrimidine derivatives as agonists of the cannabinoid receptor 2 agonists
WO2011160024A3 (en) Compounds useful as antiviral agents, compositions, and methods of use
WO2012065139A8 (en) Entpd5 inhibitors
CA2873723A1 (en) Pyrrolopyrimidone and pyrrolopyridone inhibitors of tankyrase
MX363258B (es) Compuestos piridinilpirazoloquinolina.
PH12015502118A1 (en) Pyridin-4-yl derivatives
MX351555B (es) Formas solidas de inhibidor de girasa (r)-1-etil-3-[5-[2-(1-hidrox i-1-metil-etil)pirimidin-5-il]-7-(tetrahidrofuran-2-il)-1h-benzim idazol-2-il]urea.
MX2009010483A (es) 5-oxoisoxazoles como inhibidores de lipasas y fosfolipasas.
MX346090B (es) Derivados de pirrolidina usados como inhibidores de catepsina.
AU2013314244A8 (en) Novel inhibitor compounds of phosphodiesterase type 10A
NZ602247A (en) Endoparasiticidal compositions
PH12014502747A1 (en) Phosphoramidic acid prodrugs of 5 - [5 - phenyl- 4 - (pyridin- 2 - ylmethylamino) quinazolin- 2 - yl] pyridine- 3 - sulfonamide
AU2012307449A8 (en) Sulfonic acid salts of heterocyclylamide-substituted imidazoles
MX348147B (es) Biarilsulfonamidas utiles en el tratamiento de la inflamacion y cancer.
WO2014038881A3 (ko) 피리돈 유도체를 포함하는 단백질 키나제 억제제

Legal Events

Date Code Title Description
FG Grant or registration